Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

v3.8.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Income Statement [Abstract]        
Revenues $ 340 $ 828 $ 203,640
Cost of sales 102 248
Gross profit 238 580 203,640
Operating expenses:        
Research and development 110,125 205,503 903,017 544,235
Occupancy 20,507 10,114 63,849 27,595
Depreciation and amortization 3,152 3,152 9,455 9,147
Officer compensation 108,864 105,875 571,779 105,875
Professional fees 89,457 259,381 733,823 264,209
Other operating expenses 1,783 8,513 35,624 15,281
Total operating expenses 333,888 592,538 2,317,547 966,342
Loss from operations (333,650) (592,538) (2,316,967) (762,702)
Other income (expense):        
Change in fair value of derivative 114,191 4,129,252
Interest income 2
Interest expense (108,774) (4,286) (252,968) (10,399)
Total other income (expense) 5,417 (4,286) 3,876,286 (10,399)
Income/(loss) before income taxes (328,233) (596,824) 1,559,319 (773,101)
Income tax expense
Net income/(loss) (328,233) (596,824) 1,559,319 (773,101)
Accretion on Series A preferred stock (397,591) (397,591)
Net loss attributed to common shareholders $ (328,233) $ (994,415) $ 1,559,319 $ (1,170,692)
Basic net income/(loss) per common share $ (0.01) $ (0.02) $ 0.03 $ (0.03)
Diluted net income/(loss) per common share $ (0.01) $ (0.02) $ 0.02 $ (0.03)
Basic weighted average common shares outstanding 47,269,804 41,569,112 46,135,441 41,456,782
Diluted weighted average common shares outstanding 47,269,804 41,569,112 69,561,595 41,456,782